NIQUITIN 7 mg/24 hours, medicated transdermal patch CIP 3400935719676
Active ingredients: NICOTINE
Commercialized according to BDPM
Medicated transdermal patchCIP 3400935719676transdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NIQUITIN 7 mg/24 heures, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 28 dispositif(s) en sachet(s) polytéréphtalate (PET) polyéthylène aluminium copolymère d'acrilonitrile
- Marketing authorisation holder
- LABORATOIRE PERRIGO FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Aug 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64598998CIP73571967CIP133400935719676Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NICOTINEdispositif | 36 mg · un dispositif transdermique de 7 cm2 | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.